Methemoglobinemia secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aksiniya Stevasarova, M.D.
Overview
Secondary Prevention
Secondary prevention consists of avoiding oxidizing agents in people with diagnosed G6PD deficiency or known congenital deficiency of the reductase enzyme.
References
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
